Phibro Animal Health Corp (PAHC): Total Assets
$1.50B
As of 2026-06-30
+15.6%
3-year compound annual growth
+12.3%
5-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.50B | +10.3% | 2026-08-26, Balance as of period end |
| 2025-06-30 | $1.36B | +38.6% | 2026-08-26, Balance as of period end |
| 2024-06-30 | $982.18M | +1.1% | 2025-08-27, Balance as of period end |
| 2023-06-30 | $971.40M | +4.3% | 2024-08-28, Balance as of period end |
| 2022-06-30 | $931.70M | +10.7% | 2023-08-30, Balance as of period end |
| 2021-06-30 | $841.33M | +7.3% | 2022-08-24, Balance as of period end |
| 2020-06-30 | $784.10M | +7.9% | 2021-08-25, Balance as of period end |
| 2019-06-30 | $726.67M | +8.2% | 2020-08-26, Balance as of period end |
| 2018-06-30 | $671.68M | +7.7% | 2019-08-27, Balance as of period end |
| 2017-06-30 | $623.40M | +2.6% | 2018-08-27, Balance as of period end |
| 2016-06-30 | $607.84M | +23.2% | 2017-08-30, Balance as of period end |
| 2015-06-30 | $493.32M | +4.4% | 2016-08-29, Balance as of period end |
| 2014-06-30 | $472.32M | -0.4% | 2015-09-10, Balance as of period end |
| 2013-06-30 | $474.14M | n/a | 2014-09-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.50B | +10.3% |
| Alkermes plc. (ALKS) | 2025-12-31 | $2.49B | +21.0% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $2.90B | +70.0% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.20B | -8.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $3.49B | +2.7% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.56B | +31.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $3.35B | -15.5% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $19.62B | +7.7% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
Compare PAHC, ALKS, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗